Quantcast
Home > Quotes > IONS

Ionis Pharmaceuticals, Inc. Common Stock (IONS) Quote & Summary Data

IONS 
$75
*  
2.36
3.25%
Get IONS Alerts
*Delayed - data as of Apr. 23, 2019  -  Find a broker to begin trading IONS now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    IONS Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
60
Today's High / Low
$ 75.11 / $ 72.66
Share Volume
1,110,393
50 Day Avg. Daily Volume
1,204,496
Previous Close
$ 72.64
52 Week High / Low
$ 86.582 / $ 39.07
Market Cap
10,379,831,550
P/E Ratio
39.89
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ 1.88
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.97

Intraday Chart

Shares Traded

Share Volume:
1,110,393
50 Day Avg. Daily Volume:
1,204,496

P/E Ratio

P/E Ratio:
39.89
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ 1.88

Trading Range

The current last sale of $75 is 91.96% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 75.11 $ 86.582
 Low: $ 72.66 $ 39.07

ETFs with IONS as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
3.34% First Trust Amex Biotech Index Fund (FBT) +3.23 (2.36%)
2.93% Principal Healthcare Innovators Index ETF (BTEC) +1.92 (6.14%)
2.29% First Trust Health Care AlphaDEX (FXH) -2.57 (-3.42%)
1.65% SPDR Series Trust SPDR S&P Biotech ETF (XBI) +7.03 (8.80%)
0.62% Vanguard Small-Cap Growth ETF (VBK) +20.44 (12.42%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We are a leader in discovering and developing RNA-targeted therapeutics with sustained and growing revenues. We have created an efficient and broadly applicable drug discovery platform leveraging our expertise in antisense oligonucleotide therapeutics that we believe has fundamentally changed medicine and transformed the lives of people with devastating and often deadly diseases. Our large, diverse and advanced pipeline of over 40 first-in-class and/or best-in-class medicines addresses diseases across a broad range of therapeutic areas, targeting small, medium and large patient populations. We have two commercial medicines approved in major markets around the world, SPINRAZA and TEGSEDI. We have at least four medicines that have entered pivotal studies or have the potential to begin pivotal studies this year, and another six medicines that could start pivotal studies in 2020.  ... More ...  



Risk Grade

Where does IONS fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 72.91
Open Date:
Apr. 23, 2019
Close Price:
$ 75
Close Date:
Apr. 23, 2019


Consensus Recommendation

Analyst Info